These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26173102)

  • 21. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
    Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Genetic Variation in a Wnt Signaling Pathway Gene (
    Yadav BK; Yadav R; Kang HG; Kim KW; Lee CH; Shin BS
    Genet Test Mol Biomarkers; 2020 Nov; 24(11):708-716. PubMed ID: 33026847
    [No Abstract]   [Full Text] [Related]  

  • 23. Molecular profile of Hürthle cell carcinomas: recurrent mutations in the Wnt/β-catenin pathway.
    Santana NO; Lerario AM; Schmerling CK; Marui S; Alves VAF; Hoff AO; Kopp P; Danilovic DLS
    Eur J Endocrinol; 2020 Dec; 183(6):647-656. PubMed ID: 33120354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knockdown of lncRNA SNHG7 inhibited cell proliferation and migration in bladder cancer through activating Wnt/β-catenin pathway.
    Chen Y; Peng Y; Xu Z; Ge B; Xiang X; Zhang T; Gao L; Shi H; Wang C; Huang J
    Pathol Res Pract; 2019 Feb; 215(2):302-307. PubMed ID: 30527358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Knockdown of mediator subunit Med19 suppresses bladder cancer cell proliferation and migration by downregulating Wnt/β-catenin signalling pathway.
    Yuan H; Yu S; Cui Y; Men C; Yang D; Gao Z; Zhu Z; Wu J
    J Cell Mol Med; 2017 Dec; 21(12):3254-3263. PubMed ID: 28631286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HBO1 promotes cell proliferation in bladder cancer via activation of Wnt/β-catenin signaling.
    Chen Z; Zhou L; Wang L; Kazobinka G; Zhang X; Han X; Li B; Hou T
    Mol Carcinog; 2018 Jan; 57(1):12-21. PubMed ID: 28796367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of metastasis of bladder cancer cells through the WNT signaling pathway.
    Du Y; Wang Y; Zhang F; Wu W; Wang W; Li H; Xia S; Liu H
    Tumour Biol; 2015 Nov; 36(11):8839-44. PubMed ID: 26069102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathway Analyses Identify Novel Variants in the WNT Signaling Pathway Associated with Tuberculosis in Chinese Population.
    Hu X; Zhou J; Chen X; Zhou Y; Song X; Cai B; Zhang J; Lu X; Ying B
    Sci Rep; 2016 Jun; 6():28530. PubMed ID: 27334567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of microRNA-135a on the epithelial-mesenchymal transition, migration and invasion of bladder cancer cells by targeting GSK3β through the Wnt/β-catenin signaling pathway.
    Mao XW; Xiao JQ; Li ZY; Zheng YC; Zhang N
    Exp Mol Med; 2018 Jan; 50(1):e429. PubMed ID: 29350680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LGR5 promotes the proliferation and tumor formation of cervical cancer cells through the Wnt/β-catenin signaling pathway.
    Chen Q; Cao HZ; Zheng PS
    Oncotarget; 2014 Oct; 5(19):9092-105. PubMed ID: 25193857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-3619-5p suppresses bladder carcinoma progression by directly targeting β-catenin and CDK2 and activating p21.
    Zhang Q; Miao S; Han X; Li C; Zhang M; Cui K; Xiong T; Chen Z; Wang C; Xu H
    Cell Death Dis; 2018 Sep; 9(10):960. PubMed ID: 30237499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A hypermorphic epithelial β-catenin mutation facilitates intestinal tumorigenesis in mice in response to compounding WNT-pathway mutations.
    Buchert M; Rohde F; Eissmann M; Tebbutt N; Williams B; Tan CW; Owen A; Hirokawa Y; Gnann A; Orend G; Orner G; Dashwood RH; Heath JK; Ernst M; Janssen KP
    Dis Model Mech; 2015 Nov; 8(11):1361-73. PubMed ID: 26398937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Target inhibition on GSK-3β by miR-9 to modulate proliferation and apoptosis of bladder cancer cells.
    Dong ZC; Zhang D; Wang SB; Lin ZQ
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3018-3026. PubMed ID: 29863246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic variation in Wnt/β-catenin and ER signalling pathways in female and male elite dancers and its associations with low bone mineral density: a cross-section and longitudinal study.
    Amorim T; Durães C; Machado JC; Metsios GS; Wyon M; Maia J; Flouris AD; Marques F; Nogueira L; Adubeiro N; Koutedakis Y
    Osteoporos Int; 2018 Oct; 29(10):2261-2274. PubMed ID: 29978256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TMEM88 exhibits an antiproliferative and anti-invasive effect in bladder cancer by downregulating Wnt/β-catenin signaling.
    Zhao X; Li G; Chong T; Xue L; Luo Q; Tang X; Zhai X; Chen J; Zhang X
    J Biochem Mol Toxicol; 2021 Aug; 35(8):e22835. PubMed ID: 34057764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulated GBX2 gene suppresses proliferation, invasion and angiogenesis of breast cancer cells through inhibiting the Wnt/β-catenin signaling pathway.
    Fang Y; Yuan Y; Zhang LL; Lu JW; Feng JF; Hu SN
    Cancer Biomark; 2018; 23(3):405-418. PubMed ID: 30223390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiRNA-139-3p inhibits malignant progression in urothelial carcinoma of the bladder via targeting KIF18B and inactivating Wnt/beta-catenin pathway.
    Zhang W; Liu Z
    Pharmacogenet Genomics; 2023 Jan; 33(1):1-9. PubMed ID: 36441170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma.
    Chen Q; Zheng PS; Yang WT
    Oncotarget; 2016 Jun; 7(24):36115-36129. PubMed ID: 27092879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of hepaCAM inhibits bladder cancer cell proliferation via a Wnt/β-catenin-dependent pathway in vitro and in vivo.
    Du HF; Ou LP; Lv CK; Yang X; Song XD; Fan YR; Wu XH; Luo CL
    Cancer Biol Ther; 2015; 16(10):1502-13. PubMed ID: 26192362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Canonical Wnt/β-Catenin Pathway and Type 2 Diabetes: Genetic Epidemiological Study in Han Chinese.
    Wang J; Zhao J; Zhang J; Luo X; Gao K; Zhang M; Li L; Wang C; Hu D
    Nutrients; 2015 Jun; 7(6):4763-77. PubMed ID: 26083111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.